Showing results (211-220 of 412) with videos related to

Sort By:
Pageof 42
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 8, 2006
Role of 18F-FDG-PET and PET/CT imaging in thyroid cancerCristina Nanni, Domenico Rubello, Stefano Fanti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2014
Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?Sotirios Chondrogiannis, Maria Cristina Marzola, Alice Ferretti, et al.
Nuclear Medicine Communications|November 7, 2008
Radiation emission dose from patients administered 90Y-labelled radiopharmaceuticals: comparison of experimental measurements versus Monte Carlo simulationSergio Lo Meo, Gianfranco Cicoria, Giancarlo Montini, et al.
Nuclear Medicine Communications|January 21, 2015
Response criteria for malignant lymphomaAnna M Maffione, Rossella Paolini, Elisabetta Rodella, et al.
Clinical Nuclear Medicine|October 11, 2012
Preoperative diagnosis of orbital cavernous hemangioma: a 99mTc-RBC SPECT studyLuca Burroni, Giulia Borsari, Patrizia Pichierri, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 25, 2008
Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PETStefano Fanti, Valentina Ambrosini, Paola Tomassetti, et al.
PET Clinics|May 10, 2016
Nuclear Medicine in Early-Stage Melanoma: Sentinel Node Biopsy-FDG-PET/CTElif Hindié, Farid Sarandi, Soraya Banayan, et al.
Molecular Imaging and Biology|August 12, 2010
68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumoursMeeran Naji, Chunlei Zhao, Sarah J Welsh, et al.
Nuclear Medicine Communications|May 29, 2004
Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experienceMaria Rosa Pelizzo, Isabella Merante Boschin, Antonio Toniato, et al.
Pageof 42